Xos (XOS) director sells 7,500 shares, receives RSUs

Rhea-AI Filing Summary

Xos, Inc. (XOS) reports an amended Form 4 for director Alice Yake, correcting prior transaction codes to reflect that certain dispositions were open‑market sales under a Rule 10b5-1 trading plan. On July 10, 2026 she received 60,584 RSUs subject to future vesting and 2,292 immediately vested RSUs in lieu of cash fees. She then sold 2,500 common shares on each of July 10, 13, and 14, 2026 at weighted average prices of $2.4916, $2.3483, and $2.3948 per share, respectively. The amendment states no other information from the original Form 4 has changed.

Insider Trade Summary 10b5-1

Net Buyer: 55,376 shares

Net Buy 5 txns

Insider Yake Alice

Role Director

Sold 7,500 shs ($18K)

Type	Security	Shares	Price	Value
Sale	Common Stock F4, F7, F2	2,500	$2.3948	$6K
Sale	Common Stock F4, F6, F2	2,500	$2.3483	$6K
Grant/Award	Common Stock F1, F2	60,584	$0.00	$0.00
Grant/Award	Common Stock F3, F2	2,292	$0.00	$0.00
Sale	Common Stock F4, F5, F2	2,500	$2.4916	$6K

Holdings After Transaction: Common Stock — 160,061 shares (Direct)

Footnotes (7)

1. F1. The shares reported in this transaction represent Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day before the Company's 2027 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date.
2. F2. Includes 60,584 unvested RSUs.
3. F3. The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer fees for the Reporting Person's service as a non-employee director and as Nominating and Corporate Governance Committee Chair in the second quarter of 2026. The RSUs reported vested immediately on the date of grant.
4. F4. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.
5. F5. Represents weighted average sales price. The shares were sold at prices ranging from $2.46 to $2.59. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
6. F6. Represents weighted average sales price. The shares were sold at prices ranging from $2.325 to $2.44. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
7. F7. Represents weighted average sales price. The shares were sold at prices ranging from $2.35 to $2.43. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Key Figures

RSUs granted: 60,584 RSUs RSUs in lieu of cash fees: 2,292 RSUs Shares sold July 10, 2026: 2,500 shares at $2.4916 per share +4 more

7 metrics

RSUs granted 60,584 RSUs Unvested RSUs granted on July 10, 2026; each RSU equal to one share

RSUs in lieu of cash fees 2,292 RSUs Issued for second quarter 2026 director and committee chair fees; vested immediately

Shares sold July 10, 2026 2,500 shares at $2.4916 per share Open‑market sale of common stock pursuant to Rule 10b5-1 plan

Shares sold July 13, 2026 2,500 shares at $2.3483 per share Open‑market sale of common stock pursuant to Rule 10b5-1 plan

Shares sold July 14, 2026 2,500 shares at $2.3948 per share Open‑market sale of common stock pursuant to Rule 10b5-1 plan

Total shares sold 7,500 shares Aggregate of three 2,500‑share sales on July 10, 13, and 14, 2026

Rule 10b5-1 plan adoption date September 29, 2025 Trading plan under which the reported sales were effected

Key Terms

Rule 10b5-1 trading plan, Restricted Stock Units ("RSUs"), weighted average sales price

3 terms

Rule 10b5-1 trading plan regulatory

"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Restricted Stock Units ("RSUs") financial

"The shares reported in this transaction represent Restricted Stock Units ("RSUs"), each of which"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average sales price financial

"Represents weighted average sales price. The shares were sold at prices ranging from"

FAQ

What does the amended Form 4/A disclose for XOS director Alice Yake?

It discloses that Alice Yake received 60,584 RSUs on July 10, 2026 subject to vesting, plus 2,292 RSUs that vested immediately in lieu of cash director fees, and that she sold 2,500 shares on each of July 10, 13, and 14, 2026 under a Rule 10b5-1 plan.

What correction does this Form 4/A make for XOS?

The amendment states that prior dispositions on July 10, 13, and 14, 2026 were incorrectly reported with transaction code D. They are corrected to code S, indicating open‑market sales pursuant to a Rule 10b5-1 trading plan. No other data from the original Form 4 is changed.

How many XOS shares did Alice Yake sell according to the amended Form 4?

She sold 7,500 shares of Xos, Inc. common stock in total, in three equal blocks of 2,500 shares each on July 10, 13, and 14, 2026, at weighted average prices between about $2.35 and $2.49 per share.

What are the key terms of the 60,584 RSUs reported for XOS?

The 60,584 RSUs each represent a contingent right to receive one share of Xos, Inc. common stock. They vest on the earlier of the first anniversary of the grant date or the day before the company’s 2027 Annual Meeting, subject to continued service.

What RSUs did Alice Yake receive instead of cash fees from XOS?

She received 2,292 RSUs issued in lieu of cash retainer fees for her service as a non‑employee director and Nominating and Corporate Governance Committee Chair for the second quarter of 2026. These RSUs vested immediately on the grant date.

Were Alice Yake’s XOS share sales under a trading plan?

Yes. Footnotes state that the reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025, and the filing’s Rule 10b5-1 checkbox is affirmed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/27/2026 - 07:30 AM Accepted by SEC EDGAR 08/27/2026 - 07:30 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yake Alice

(Last) (First) (Middle)

C/O XOS, INC.

3550 TYBURN STREET, UNIT 100

(Street)

LOS ANGELES CALIFORNIA 90065

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xos, Inc. [ XOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/14/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/10/2026		A		60,584(1)	A	$0.00	165,269(2)	D
Common Stock	07/10/2026		A		2,292(3)	A	$0.00	167,561(2)	D
Common Stock	07/10/2026		S		2,500(4)	D	$2.4916(5)	165,061(2)	D
Common Stock	07/13/2026		S		2,500(4)	D	$2.3483(6)	162,561(2)	D
Common Stock	07/14/2026		S		2,500(4)	D	$2.3948(7)	160,061(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported in this transaction represent Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest on the earlier of (i) the first anniversary of the Grant date and (ii) the day before the Company's 2027 Annual Meeting, subject to the Reporting Person's continuous service with Xos, Inc. through the vesting date.

2. Includes 60,584 unvested RSUs.

3. The shares reported in this transaction represent RSUs that were issued to the Reporting Person in lieu of the cash retainer fees for the Reporting Person's service as a non-employee director and as Nominating and Corporate Governance Committee Chair in the second quarter of 2026. The RSUs reported vested immediately on the date of grant.

4. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

5. Represents weighted average sales price. The shares were sold at prices ranging from $2.46 to $2.59. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

6. Represents weighted average sales price. The shares were sold at prices ranging from $2.325 to $2.44. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

7. Represents weighted average sales price. The shares were sold at prices ranging from $2.35 to $2.43. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Remarks:

This Amendment is filed solely to correct the Transaction Codes for the transactions involving disposition of securities on July 10, 2026, July 13, 2026 and July 14, 2026. Due to an administrative error, the transactions were incorrectly reported using Code 'D'. The shares were actually sold on the open market pursuant to a Rule 10b5-1 trading plan as indicated in footnote 3, and should have been designated as Code 'S'. There are no changes to the other information reported in the original Form 4.

	/s/ David M. Zlotchew, Attorney-in-Fact for Alice Yake	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)